These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31413308)

  • 1. Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance.
    Torrea G; Ng KCS; Van Deun A; André E; Kaisergruber J; Ssengooba W; Desmaretz C; Gabriels S; Driesen M; Diels M; Asnong S; Fissette K; Gumusboga M; Rigouts L; Affolabi D; Joloba M; De Jong BC
    Sci Rep; 2019 Aug; 9(1):11826. PubMed ID: 31413308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant
    He G; Zheng Q; Wu J; Wu L; Geng Z; Jiang G; Huang H; Jiang X; Yu X
    Microbiol Spectr; 2024 Jun; 12(6):e0385923. PubMed ID: 38738892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
    Abanda NN; Djieugoué JY; Khadka VS; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Deng Y; Eyangoh SI; Taylor DW; Leke RGF
    Clin Microbiol Infect; 2018 Jul; 24(7):781.e1-781.e3. PubMed ID: 29217277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Disputed Mutations in the
    Miotto P; Cabibbe AM; Borroni E; Degano M; Cirillo DM
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29540456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.
    Rahman A; Sahrin M; Afrin S; Earley K; Ahmed S; Rahman SM; Banu S
    PLoS One; 2016; 11(4):e0152694. PubMed ID: 27054344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays.
    André E; Goeminne L; Colmant A; Beckert P; Niemann S; Delmee M
    Clin Microbiol Infect; 2017 Apr; 23(4):267.e5-267.e7. PubMed ID: 27998822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. True rifampicin resistance missed by the MGIT: prevalence of this pheno/genotype in the UK and Ireland after 18 month surveillance.
    Gonzalo X; Claxton P; Brown T; Montgomery L; Fitzgibbon M; Laurenson I; Drobniewski F
    Clin Microbiol Infect; 2017 Apr; 23(4):260-263. PubMed ID: 27903459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of Mycobacterium tuberculosis presenting unusually high discordance between genotypic and phenotypic resistance to rifampicin in an endemic tuberculosis setting.
    Brandao AP; Pinhata JMW; Simonsen V; Oliveira RS; Ghisi KT; Rabello MCS; Fukasava S; Ferrazoli L
    Tuberculosis (Edinb); 2020 Dec; 125():102004. PubMed ID: 33017720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of rpoB gene mutations in isolates from tuberculosis patients in Cubal, Republic of Angola.
    Rando-Segura A; Aznar ML; Moreno MM; Espasa Soley M; Sulleiro Igual E; Bocanegra Garcia C; Gil Olivas E; Nindia Eugénio A; Escartin Huesca C; Zacarias A; Vegue Collado J; Katimba D; Vivas Cano MC; Gabriel E; López García MT; Pumarola Suñe T; Molina Romero I; Tórtola Fernández MT
    BMC Infect Dis; 2021 Oct; 21(1):1056. PubMed ID: 34641802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients.
    Van Deun A; Aung KJ; Hossain A; de Rijk P; Gumusboga M; Rigouts L; de Jong BC
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):185-90. PubMed ID: 25574917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.
    Yoo IY; Huh HJ; Kang OK; Jhun BW; Koh WJ; Lee NY
    Respir Med; 2019 Jan; 146():71-75. PubMed ID: 30665521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic Tests.
    Ardizzoni E; Ariza E; Mulengwa D; Mpala Q; de La Tour R; Maphalala G; Varaine F; Kerschberger B; Graulus P; Page AL; Niemann S; Dreyer V; Van Deun A; Decroo T; Rigouts L; de Jong BC
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Level Rifampin Resistance and
    Shea J; Halse TA; Kohlerschmidt D; Lapierre P; Modestil HA; Kearns CH; Dworkin FF; Rakeman JL; Escuyer V; Musser KA
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 32999007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comprehensive identification of compensatory mutations in rifampicin-resistant
    Zuo TY; Liu QY; Gan MY; Gao Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Mar; 41(3):207-212. PubMed ID: 29518850
    [No Abstract]   [Full Text] [Related]  

  • 18. Compensatory effects of
    Ma P; Luo T; Ge L; Chen Z; Wang X; Zhao R; Liao W; Bao L
    Emerg Microbes Infect; 2021 Dec; 10(1):743-752. PubMed ID: 33775224
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations.
    Rigouts L; Gumusboga M; de Rijk WB; Nduwamahoro E; Uwizeye C; de Jong B; Van Deun A
    J Clin Microbiol; 2013 Aug; 51(8):2641-5. PubMed ID: 23761146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.